Universitätsklinikum Ulm

AGO Recommendations for the diagnosis and treatment of patients with advanced and metastatic breast cancer: Update 2017 (2017) Thill M, Liedtke C, Solomayer EF, Mueller V, Janni W, Schmidt M Journal article Complement C5a functions as a master switch for the pH balance in neutrophils exerting fundamental immunometabolic effects (2017) Denk S, Neher MD, Messerer DAC, Wiegner R, Nilsson B, Rittirsch D, Nilsson-Ekdahl K, et al. Journal article IKZF1 expression is a prognostic marker in newly diagnosed standard-risk multiple myeloma treated with lenalidomide and intensive chemotherapy: A study of the German Myeloma Study Group (DSMM) (2017) Kroenke J, Kuchenbauer F, Kull M, Teleanu V, Bullinger L, Bunjes D, Greiner A, et al. Journal article Digital Mapping of the Urinary Bladder: Potential for Standardized Cystoscopy Reports. (2017) Kriegmayr M, Bergen T, Ritter M, Mandel P, Michel M, Wittenberg T, Bolenz C Journal article, Original article Long-term survival of patients with CLL after allogeneic transplantation: A report from the European Society for Blood and Marrow Transplantation (2017) Van Gelder M, De Wreede LC, Bornhaeuser M, Niederwieser D, Karas M, Anderson NS, Gramatzki M, et al. Journal article Alpha-synuclein prevents the formation of spherical mitochondria and apoptosis under oxidative stress (2017) Winner B, Menges S, Minakaki G, Schaefer P, Meixner H, Prots I, Schlötzer-Schrehardt U, et al. Journal article Impact of donor activating KIR genes on HSCT outcome in C1-ligand negative myeloid disease patients transplanted with unrelated donors - A retrospective study (2017) Neuchel C, Fuerst D, Niederwieser D, Bunjes D, Tsamadou C, Wulf G, Pfreundschuh M, et al. Journal article Validation of the DAPT score in patients randomized to 6 or 12 months clopidogrel after predominantly second-generation drug-eluting stents (2017) Harada Y, Michel J, Lohaus R, Mayers K, Emmer R, Lahmann AL, Colleran R, et al. Journal article RECREATE - A retrospective chart review to assess the treatment reality for mRCC patients following 1st line Pazopanib: reflecting a changing mRCC treatment landscape (2017) Hegele A, Van Der Heyde E, Goebell P, Zengerling F, Hbner A, Klier J, Belz H, et al. Conference contribution Randomised, open-label, phase II study comparing the efficacy and the safety of cabazitaxel versus weekly paclitaxel given as neoadjuvant treatment in patients with operable triple-negative or luminal B/HER2-negative breast cancer (GENEVIEVE) (2017) Kuemmel S, Paepke S, Huober J, Schem C, Untch M, Blohmer JU, Eiermann W, et al. Journal article